A cross-sectional survey among participants in India and South Africa to explore perceptions and awareness of SARS-CoV-2-related risks. Main outcome measures-proportion of participants aware of SARS-CoV-2, and their perception of
infection risks as it related to their views and perceptions on vaccination, i.e., using
COVID-19 vaccine uptake as proxy for awareness level. Self-administered questionnaires were used to collect data via web- and paper-based surveys over three months. Pearson's Chi-squared test assessed relationships between variables; a p-value less than 0.05 was considered significant. There were 844 respondents (India: n = 660, South Africa: n = 184; response rate 87.6%), with a 61.1% vs 38.3% female to male ratio. Post-high-school or university education was the lowest qualification reported by most respondents in India (77.3%) and South Africa (79.3%). Sources of pandemic information were usually media and journal publications (73.2%), social media (64.6%), family and friends (47.7%) and government websites (46.2%). Most respondents correctly identified
infection prevention measures (such as physical distancing, mask use), with 90.0% reporting improved
hand hygiene practices since the pandemic. Hesitancy or refusal to accept the
SARS-CoV-2 vaccine was reported among 17.9% and 50.9% of respondents in India and South Africa, respectively; reasons cited included rushed
vaccine development and the futility of
vaccines for what respondents considered a self-limiting flu-like illness. In South Africa,
vaccine acceptance was associated with improved
hand hygiene practices since the pandemic and flu vaccination in the preceding year. No relationship was noted between awareness and practice of
infection prevention measures (such as
hand hygiene) and socio-demographic factors such as employment status or availability of amenities. Pandemic response and
infection prevention and control measures through vaccination campaigns should consider robust public engagement and contextually-fit communication strategies with multimodal, participatory online and offline initiatives to address public concerns, specifically towards
vaccines developed for this pandemic and general vaccine hesitancy.